default author photo

Ivan Noreña

Ludwig Maximilian University of Munich (LMU)

SCHOLARLY PAPERS

2

DOWNLOADS

178

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

A Prospective, Randomised, Open Label Phase 2b Dose-Finding ​Trial of Delpazolid in Combination with Bedaquiline, Delamanid and Moxifloxacin for Pulmonary Tuberculosis: DECODE

Number of pages: 16 Posted: 10 Dec 2024
National Institute for Medical Research (NIMR), Radboud University Nijmegen - Radboud University Medical Center, National Institute for Medical Research (NIMR), Kibong’oto Infectious Diseases Hospital, Ifakara Health Institute, Ludwig Maximilian University of Munich (LMU), Aurum Institute, University of the Witwatersrand, Aurum Institute, National Institute for Medical Research (NIMR), Kibong’oto Infectious Diseases Hospital, Ifakara Health Institute, Ludwig Maximilian University of Munich (LMU), Ifakara Health Institute, Kibong’oto Infectious Diseases Hospital, Aurum Institute, University of St Andrews, Radboud University Nijmegen - Department of Lung Disease, Radboud University Nijmegen - Radboud University Medical Center, Radboud University Nijmegen - Radboud Institute for Health Sciences, University College London, University College London, Radboud University Nijmegen - Department of Lung Disease, LigaChem Biosciences Inc, LigaChem Biosciences Inc, University of California, San Francisco (UCSF), University of California, San Francisco (UCSF) - UCSF Center for Tuberculosis, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, Radboud University Nijmegen - Radboud Institute for Health Sciences, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine and Independent
Downloads 132 (554,631)

Abstract:

Loading...

Pulmonary tuberculosis, oxazolidinones, phase 2b, randomised clinical trial

2.

Blood Transcriptomic and Clinical Biomarkers for Prediction of Tuberculosis Recurrence: A Multi-Country Validation Study​

Number of pages: 26 Posted: 19 Apr 2026
Ludwig Maximilian University of Munich (LMU), Ludwig Maximilian University of Munich (LMU), Ludwig Maximilian University of Munich (LMU), Ludwig Maximilian University of Munich (LMU), Ludwig Maximilian University of Munich (LMU), Ifakara Health Institute, Kibong’oto Infectious Diseases Hospital, National Institute for Medical Research (NIMR), University of Cape Town Lung Institute, TASK, University of the Witwatersrand, Aurum Institute, Radboud University Nijmegen - Radboud University Medical Center, Ludwig Maximilian University of Munich (LMU), Technische Universität München (TUM), Ludwig Maximilian University of Munich (LMU), Ludwig Maximilian University of Munich (LMU) - CIHLMU Center for International Health and Ludwig Maximilian University of Munich (LMU)
Downloads 46 (1,236,159)

Abstract:

Loading...

tuberculosis, outcome prediction, biomarkers, multi-country validation, clinical trial